WS #9858

The dominant market-moving signal in this window is the continued confirmation and market impact of the US-Iran peace deal, which is now being detailed by multiple sources. The deal includes reopening the Strait of Hormuz, lifting the US naval blockade, and a signing ceremony set for June 19 in Geneva. This has triggered a sharp decline in oil prices (WTI -5.36%, Brent -5.08%) and a broad equity market rally (S&P 500 +1.34%, Nasdaq +2.18%). The IMF has welcomed the deal, and pressure on the Fed to hike rates is easing. However, Hezbollah has rejected linking Israeli withdrawal to domestic issues, and Israeli airstrikes on Beirut's southern suburbs indicate residual geopolitical risk. Separately, Fiserv CEO abruptly exits for Truist, causing FISV stock to drop 8%. Salesforce acquires AI customer service platform Fin for $3.6 billion. KeyBanc upgrades Rocket Lab and Firefly to Overweight, citing SpaceX IPO selloff as buying opportunity. Eli Lilly's retatrutide hits 30.3% mean weight loss at 104 weeks in TRIUMPH-1 extension, all endpoints met. Robinhood director Malka Meyer drops $35M+ on HOOD stock in two open-market buys, a rare insider purchase. The prevailing narrative is the US-Iran peace deal, which is ESCALATING in terms of confirmed details and market impact, but with counter-signals from Hezbollah and Israeli airstrikes.